MyChesCo on MSN3h
FDA Approves GSK’s Blujepa as First New Oral Antibiotic for UTIs in 30 Years
The U.S. Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin), a groundbreaking oral antibiotic for ...
Millions of women get painful UTIs that keep coming back. A new kind of antibiotic may help break the cycle
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
Everyday Health on MSN3d
FDA Approves the First New UTI Antibiotic in Nearly 30 Years
This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...
US approves new antibiotic for urinary tract infections
US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 ...
The American Journal of Managed Care5d
FDA Approves First New Class of Oral Antibiotics for Uncomplicated UTIs in Nearly 30 Years
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
McKnight's Long-Term Care News3d
FDA approves gepotidacin antibiotic for uncomplicated urinary tract infections
The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...
4029tv5d
FDA approves a new kind of oral antibiotic to treat urinary tract infections
the first in a new class of oral antibiotics for [uncomplicated UTIs] in nearly three decades, and to bring another option to patients given recurrent infections and rising rates of resistance to ...
MedCity News4d
FDA Approves First-in-Class GSK Antibiotic for Common Type of Urinary Tract Infection
A GSK pill that offers a lower potential for drug resistance is now FDA approved as a new treatment for a common type of urinary tract infection, the first new oral antibiotic for this indication ...
WLWT5d
FDA approves a new kind of oral antibiotic to treat urinary tract infections
""We are proud to have developed Blujepa, the first in a new class of oral antibiotics for in nearly three decades, and to bring another option to patients given recurrent infections and rising ...